EDIT Editas Medicine Inc

Editas Medicine Inc is a genome editing company which is engaged in treating patients with genetically defined diseases by correcting disease-causing genes.

$39.33  -1.43 (-3.51%)
As of 04/09/2021 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/03/2016
Outstanding shares:  67,362,791
Average volume:  1,541,289
Market cap:   $2,658,135,733
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    28106W103
ISIN:        US28106W1036
Sedol:      BZ8FPH3
Valuation   (See tab for details)
PE ratio:   -22.92
PB ratio:   6.27
PS ratio:   29.30
Return on equity:   -29.47%
Net income %:   -127.82%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy